SCHEMBL30980528

SCHEMBL30980528

CC(=O)N[C@@H]1[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H](COCc2ccccc2)O[C@@H]1C#CC#CCOCCOCCNC(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.41
▸ MDM2 Q00987 2/20 0.41
▸ MDM4 O15151 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ PTPN1 P18031 6/20 0.41
▸ CDC25B P30305 6/20 0.41
▸ PTPN2 P17706 4/20 0.41
▸ CDC25A P30304 3/20 0.41
▸ PTPN6 P29350 1/20 0.41
▸ PTPN11 Q06124 1/20 0.41
▸ NT5E P21589 1/20 0.36
▸ BCHE P06276 2/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ TACR1 P25103 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ DDB1 Q16531 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31078995 0.92 LMNA (0.43) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980693 0.84 PTPN1 (0.47) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980639 0.82 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980622 0.80 TP53 (0.47) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980581 0.78 TP53 (0.43) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980474 0.78 PTPN1 (0.47) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980746 0.77 TP53 (0.44) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980750 0.75 PTPN1 (0.47) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL31734181 0.75 TP53 (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980533 0.74 TP53 (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback